These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10434891)

  • 41. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
    Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
    Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
    Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
    J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.
    Murtas D; Piras F; Minerba L; Ugalde J; Floris C; Maxia C; Demurtas P; Perra MT; Sirigu P
    Oncol Rep; 2010 Feb; 23(2):329-35. PubMed ID: 20043092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of the OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer.
    Rowley S; Carpenter R; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
    Eur J Surg Oncol; 1991 Aug; 17(4):370-8. PubMed ID: 1874294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.
    Poyraz A; Akyürek N; Gönül II; Erdem O
    J Exp Clin Cancer Res; 2004 Dec; 23(4):625-31. PubMed ID: 15743033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic significance of c-myc oncogene expression in uveal melanoma.
    Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD
    Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.
    Weinlich G; Topar G; Eisendle K; Fritsch PO; Zelger B
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):669-77. PubMed ID: 17447982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
    Hazan C; Melzer K; Panageas KS; Li E; Kamino H; Kopf A; Cordon-Cardo C; Osman I; Polsky D
    Cancer; 2002 Aug; 95(3):634-40. PubMed ID: 12209757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastrointestinal stromal tumor markers in cutaneous melanomas: relationship to prognostic factors and outcome.
    Gonzalez RS; Carlson G; Page AJ; Cohen C
    Am J Clin Pathol; 2011 Jul; 136(1):74-80. PubMed ID: 21685034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions.
    Korabiowska M; Brinck U; Mirecka J; Kellner S; Marx D; Schauer A
    In Vivo; 1995; 9(5):433-8. PubMed ID: 8900920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma.
    Grover R; Ross DA; Wilson GD; Sanders R
    Br J Plast Surg; 1997 Oct; 50(7):478-82. PubMed ID: 9422944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
    Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
    Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic prediction of the immunohistochemical expression of p16 and p53 in cutaneous melanoma: a comparison of two populations from different geographical regions.
    Sirigu P; Piras F; Minerba L; Murtas D; Maxia C; Colombari R; Corbu A; Perra MT; Ugalde J
    Eur J Histochem; 2006; 50(3):191-8. PubMed ID: 16920642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of milk fat globule epidermal growth factor-VIII may be an indicator of poor prognosis in malignant melanoma.
    Oba J; Moroi Y; Nakahara T; Abe T; Hagihara A; Furue M
    Br J Dermatol; 2011 Sep; 165(3):506-12. PubMed ID: 21574974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression of P53 protein in cutaneous melanoma].
    Casazza S; Gambini C; Tunesi G; Rovida S; Caruso F; Pastorino A; Canepa M
    Pathologica; 1993; 85(1097):335-42. PubMed ID: 8233650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique.
    Spandidos DA; Field JK; Agnantis NJ; Evan GI; Moore JP
    Anticancer Res; 1989; 9(4):821-6. PubMed ID: 2683996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma.
    Gammon B; Ali L; Guitart J; Gerami P
    Am J Dermatopathol; 2012 Jul; 34(5):487-90. PubMed ID: 22456513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.